| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President and CEO | President and CEO
2 companies
Hung David serves as a President and CEO at NUVB and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 3 buys and 2 sells. Those positions are worth an estimated $105.9M at current prices.
Historically, Hung David's trades have earned a middling insider score of 69/100 across 4 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +75.0%.
The biggest single holding is NUVB (~$105.9M) as President and CEO. Net of sales, the recent Form 4 record there shows accumulation of 1,000,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | NVCR Novocure Limited | Director | Sell | 2,945 | $15.77 | $46,444.71 | -12.6% | +11.6% | - | |
| Jun 16, 2025 | NUVB Nuvation Bio Inc. | President and CEO | Buy | 500,000 | $1.79 | $893,500.00 | +0.9% | +69.4% | +164.5% | |
| Jun 3, 2025 | NVCR Novocure Ltd | Director | Sell | 999 | $17.30 | $17,279.50 | -7.6% | -28.5% | +0.0% | |
| Apr 7, 2025 | NUVB Nuvation Bio Inc. | President and CEO | Buy | 500,000 | $1.64 | $820,220.00 | +0.9% | +15.6% | +150.6% |